Drug Shortage Report for ALVESCO
| Report ID | 22634 |
| Drug Identification Number | 02285614 |
| Brand name | ALVESCO |
| Common or Proper name | ciclesonide |
| Company Name | COVIS PHARMA GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | CICLESONIDE |
| Strength(s) | 200MCG |
| Dosage form(s) | AEROSOL, METERED DOSE |
| Route of administration | INHALATION |
| Packaging size | 120 doses |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-10-06 |
| Actual start date | |
| Estimated end date | 2017-10-20 |
| Actual end date | 2017-10-02 |
| Shortage status | Avoided shortage |
| Updated date | 2017-10-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | GRAFENAUWEG 12 ZUG, ZUG SWITZERLAND 6300 |
| Company contact information | Covis Pharma GmbH Grafenauweg 12 Zug, 6300 Switzerland |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2017-10-02 | French | Compare |
| v4 | 2017-10-02 | English | Compare |
| v3 | 2017-09-19 | French | Compare |
| v2 | 2017-09-19 | English | Compare |
| v1 | 2017-09-19 | English | Compare |
Showing 1 to 5 of 5